MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
ATOS Atossa Therapeutics
- 0.9637
- -0.0163-1.66%
Close Dec 20 16:00 ET
- 0.9901
- +0.0264+2.74%
Post 19:36 ET
121.23MMarket Cap-4.59P/E (TTM)
1.0200High0.9600Low1.09MVolume0.9700Open0.9800Pre Close1.07MTurnover0.92%Turnover RatioLossP/E (Static)125.80MShares2.310052wk High1.64P/B113.68MFloat Cap0.770052wk Low--Dividend TTM117.97MShs Float2231.9981Historical High--Div YieldTTM6.12%Amplitude0.5000Historical Low0.9810Avg Price1Lot Size
About Atossa Therapeutics Company
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Company Profile
SymbolATOS
Company NameAtossa Therapeutics
Listing DateNov 8, 2012
Issue Price5.00
Founded2008
CEODr. Steven C. Quay, M.D.
MarketNASDAQ
Employees12
Fiscal Year Ends12-31
Address10202 5th Avenue North East,Suite 200
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98125
Phone1-206-588-0256
Company Executives
- Name
- Position
- Salary
- Dr. Steven C. Quay, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.36M
- Heather Rees
- Senior Vice President, Finance and Accounting and Principal Accounting Officer
- 687.46K
- Dr. Tessa Cigler, M.D.,M.P.H.
- Director
- --
- Dr. Shu-Chih Chen, PhD
- Director
- 116.17K
- Richard I. Steinhart
- Independent Director
- 146.17K
- Jonathan F. Finn, C.F.A.
- Independent Director
- 93.98K
- H. Lawrence Remmel
- Independent Director
- 144.92K
- Dr. Stephen J. Galli, M.D.
- Independent Director
- 144.92K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.